Development of Dihydroquinoxalinone-Based Dual CDK6/BET Inhibitors for Triple-Negative Breast Cancer Therapy
用户6X7Ch8WUQ_gI
1个月前
54
10
已完结
1. 系统已在2026-03-27 11:42:44对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: https://doi.org/10.1021/acs.jmedchem.5c03487
文献链接: https://pubs.acs.org/doi/10.1021/acs.jmedchem.5c03487
其他信息:
出版社: American Chemical Society (ACS)
作者: Long Zheng; Yiwei Zheng; Sijie Wu; Yonglei Zhang; Zhongwen Luo; Yuhan Jiang; Shunxin Guo; Meiting Zou; Lingyi Kong; Xiaobing Wang
全文下载地址: https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.5c03487
